Sleep disorders are long-term sequelae of both bacterial and viral meningitis

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 77, Issue 4, 2006, Pages 554-558

  Schmidt, H ^a   Cohrs, S ^b   Heinemann, T ^a   Goerdt, C ^a   Djukic, M ^a   Heimann, B ^c   Wallesch, C W ^c   Nau, R ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b Department of Psychiatry ^*  (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BACTERIAL MENINGITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FEMALE; GERMANY; GLASGOW COMA SCALE; GLASGOW OUTCOME SCALE; HUMAN; MALE; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; PITTSBURGH SLEEP QUALITY INDEX; PRIORITY JOURNAL; QUESTIONNAIRE; SCHLAFFRAGEBOGEN B QUESTIONNAIRE; SCORING SYSTEM; SLEEP DISORDER; SLEEP PATTERN; SLEEP TIME; VIRUS MENINGITIS;

EID: 33645574085     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2005.071142     Document Type: Article

References (44)

1. Riemann D, Voderholzer U. Primary insomnia: a risk factor to develop depression? J Affect Disord 2003;76:255-9.
2. Benca R. Consequences of insomnia and its therapies. J Clin Psychiatry 2001;62:33-8.
3. Leger D, Guilleminault C, Bader G, et al. Medical and socio-professional impact of insomnia. Sleep 2002;25:625-9.
4. Weyerer S, Dilling H. Prevalence and treatment of insomnia in the community: results from the upper Bavarian field study. Sleep 1991;21:27-36.
5. Zeitlhofer J, Schmeiser-Rieder A, Tribl G, et al. Sleep and quality of life in the Austrian population. Acta Neurol Scand 2000;102:249-57.
6. Hajak G. Epidemiology of severe insomnia and its consequences in Germany. Eur Arch Psychiatry Clin Neurosci 2001;251:49-56.
7. Merkelbach S, Sittinger H, Schweizer I, et al. Cognitive outcome after bacterial meningitis. Acta Neurol Scand 2000;102:118-23.
8. Grimwood K, Anderson V, Bond L, et al. Adverse outcomes of bacterial meningitis in school-age survivors. Pediatrics 1995;95:646-56.
9. Hotopf M, Noah N, Wessely S. Chronic fatigue and minor psychiatric morbidity after viral meningitis: a controlled study. J Neurol Neurosurg Psychiatry 1996;60:504-9.
10. Kaiser R, Vollmer H, Schmidtke K, et al. Verlauf und Prognose der FSME-Enzephalitis. Nervenarzt 1997;68:324-30.
11. Günther G, Haglund M, Lindquist L, et al. Tick-borne encephalitis in Sweden in relation to aseptic meningo-encephalitis of other etiology: a prospective study of clinical course and outcome. J Neurol 1997;244:230-8.
12. Milhaud D, Bernardin G, Roger P, et al. [Central apnea with consciousness impairment due to Listeria rhombencephalitis sequelae]. Rev Neurol (Paris) 1999;155:152-4.
13. Hasegawa T, Kohyama J, Kohji T, et al. Impairment of respiratory rhythmogenesis and sequelae of bacterial meningitis. Pediatr Neurol 1995;12:357-60.
14. Lepow M, Coyne N, Thompson L. A clinical epidemiologic and laboratory investigation of aseptic meningitis during the four year period 1955-1958: II. The clinical disease and its sequelae. N Engl J Med 1962;266:1188-93.
15. Masek K, Kadlecová O, Petrovický P. The effect of some bacterial products on temperature and sleep in rat. Z Immunitatsforsch Exp Klin Immunol 1975;149:273-82.
16. Pollmächer T, Mullington J, Korth C, et al. Influence of host defense activation on sleep in humans. Adv Neuroimmunol 1995;5:155-09.
17. Johannsen L, Toth L, Rosenthal R, et al. Somnogenic, pyrogenic, and hematologic effects of bacterial peptidoglycan. Am J physiol 1990;258:R182-6.
18. Cady A, Riveau G, Chedid L, et al. Interleukin-1-induced sleep and febrile responses differentially altered by a muramyl dipeptide derivative. Int J Immunopharmacol 1989;11:887-93.
19. Krueger J, Kubillus S, Shoham S, et al. Enhancement of slow-wave sleep by endotoxin and lipid A. Am J Physiol 1986;251:R591-7.
20. Haack M, Schuld A, Kraus T, et al. Effects of sleep on endotoxin-induced host responses in healthy men. Psychosom Med 2001;63:568-78.
21. Buysse D, Reynolds III C, Monk T, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213.
22. Görtelmeyer R. On the development of a standardized sleep inventory for the assessment of sleep. In: Kubicki S, Herrmann WM, eds. Methods of sleep research. Stuttgart: Gustav Fischer, 1981:93-8.
23. Beck A, Ward C, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-71.
24. Tandberg E, Larsen J, Karlsen K. Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a community-based study. Mov Disord 1999;14:922-7.
25. Trenkwalder C, Wetter T, Tagaya H, et al. Sleep disorders in Parkinson syndromes: the role of the dopaminergic system on motor disturbances and REM-sleep. Electroencephalogr Clin Neurophysiol 1998;107:50P.
26. Bruni O, Galli F, Guidetti V. Sleep hygiene and migraine in children and adolescents. Cephalgia 1999;19:57-9.
27. Colosimo C, Millefiorini E, Grasso M, et al. Fatigue in MS is associated with specific clinical features. Acta Neurol Scand 1995;92:353-5.
28. Ferrini-Strambi L, Filippi M, Martinelli V, et al. Nocturnal sleep study in multiple sclerosis: correlations with clinical and brain magnetic resonance imaging findings. J Neurol Sci 1994;125:194-7.
29. Schöls L, Haan J, Riess O, et al. Sleep disturbance in spinocerebellar ataxias. Neurology 1998;51:1603-7.
30. Wiegand M, Möller A, Lauer C, et al. Nocturnal sleep in Huntington's disease. J Neurol 1991;238:203-8.
31. Guilleminault C, Philipe P, Robinson A. Sleep and neuromuscular disease: bilevel positive airway pressure by nasal mask as a treatment for sleep disordered breathing in patients with neuromuscular disease. J Neurol Neurosurg Psychiatry 1998;65:225-8.
32. van der Meche F, Bogaard J, van der Sluys J, et al. Daytime sleep in myotonic dystrophy is not caused by sleep apnoe. J Neurol Neurosurg Psychiatry 1994;57:626-8.
33. Begin P, Mathieu J, Almirall J, et al. Relationship between chronic hypercapnia and inspiratory-muscle weakness in myotonic dystrophy. Am J Resp Crit Care Med 1997;17:492-8.
34. Gomes I, Melo A, Lucena R, et al. Prognosis of bacterial meningitis in children. Arq Neuropsiquiatr 1996;54:407-11.
35. Pikis A, Kavaliotis J, Tsikoulas J, et al. Long-term sequelae of pneumococcal meningitis in children. Clin Pediatr (Phila) 1996;35:72-8.
36. Hodgson A, Smith T, Gagneux S, et al. Survival and sequelae of meningococcal meningitis in Ghana. Int J Epidemiol 2001;30:1440-6.
37. Mundigler G, Delle-Karth G, Koreny M, et al. Impaired circadian rhythm of melatonin secretion in sedated critically ill patients with severe sepsis. Crit Care Med 2002;30:536-40.
38. Spranger M, Krempien S, Schwab S, et al. Excess glutamate in the cerebrospinal fluid in bacterial meningitis. J Neurol Sci 1996;143:126-31.
39. Spranger M, Schwab S, Krempien S, et al. Excess glutamate levels in the cerebrospinal fluid predict clinical outcome of bacterial meningitis. Arch Neurol 1996;53:992-6.
40. Heyes MP, Saito K, Crowley JS, et al. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 1992;115:1249-73.
41. Leib S, Kim Y, Ferriero D, et al. Neuroprotective effect of excitatory amino acid antagonist kynurenic acid in experimental bacterial meningitis. J Infect Dis 1996;173:166-71.
42. Medana IM, Day NPJ, Salahifar-Sabet H, et al. Metabolites of the kynurenine pathway of tryptophan metabolism in the cerebrospinal fluid of Malawian children with malaria. J Infect Dis 2003;188:844-9.
43. Denoyer M, Sallanon M, Kitahama K, et al. Reversibility of parachlorophenylalanine-induced insomnia by intrahypothalamic microinjection of L-5-hydroxytryptophan. Neuroscience 1989;28:83-94.
44. Shen E, Lai Y, Ho C, et al. Excitatory and inhibitory amino acid levels in the cerebrospinal fluids of children with neurological disorders. Acta Paediatr Taiwan 1999;40:65-9.